1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Summary
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022

01/26/2022 | 01:00am EDT

Lonza Group Ltd. announced that outlook for the full-Year 2022 remains strong, with low to mid-teens CER sales growth anticipated. Business momentum across divisions and ramp-up of growth projects will drive expansion at above-market levels.


© S&P Capital IQ 2022
All news about LONZA GROUP AG
05/25Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics an..
AQ
05/24Lonza Ties Up With Israel Biotech Fund On Biologics, Small Molecule Development, Manufa..
MT
05/24LONZA : and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics and..
PU
05/23Switzerland's Lonza to Scale Up Inhalation Capabilities at US Site
MT
05/23LONZA : to Expand Inhalation Capabilities at Tampa Site
PU
05/18Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug
MT
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
05/09LONZA GROUP AG : Ex-dividend day for Distribution from share premium account
FA
05/09LONZA GROUP AG : Ex-dividend day for final dividend
FA
05/06EuroAPI gains on market debut after spin-off from Sanofi
RE
More news
Analyst Recommendations on LONZA GROUP AG
More recommendations
Financials
Sales 2022 6 152 M 6 433 M 6 433 M
Net income 2022 1 064 M 1 112 M 1 112 M
Net cash 2022 423 M 442 M 442 M
P/E ratio 2022 39,9x
Yield 2022 0,58%
Capitalization 42 496 M 44 437 M 44 437 M
EV / Sales 2022 6,84x
EV / Sales 2023 6,09x
Nbr of Employees 16 218
Free-Float 98,6%
Chart LONZA GROUP AG
Duration : Period :
Lonza Group AG Technical Analysis Chart | LONN | CH0013841017 | MarketScreener
Technical analysis trends LONZA GROUP AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 572,80 CHF
Average target price 796,79 CHF
Spread / Average Target 39,1%
EPS Revisions
Managers and Directors
Pierre-Alain Ruffieux Chief Executive Officer
Philippe Deecke Chief Financial Officer
Albert M. Baehny Chairman
Stefan Stoffel Head-Small Molecules Exclusive Synthesis Operation
Barbara May Richmond Independent Director
Sector and Competitors
1st jan.Capi. (M$)
LONZA GROUP AG-24.79%44 437
MODERNA, INC.-41.86%58 733
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026
ICON PUBLIC LIMITED COMPANY-26.61%18 478
CELLTRION, INC.-21.21%17 245